<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Expression of CD43 by B cells is often used as a diagnostic criterion in favor of a B-cell <z:hpo ids='HP_0005523'>lymphoproliferative disorder</z:hpo>, including small lymphocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>/<z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo>, mantle cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, precursor B-lymphoblastic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>, and a subset of marginal zone B-cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Benign B cells generally do not coexpress CD43 </plain></SENT>
<SENT sid="2" pm="."><plain>The authors analyzed 20 biopsies of the terminal ileum for <z:e sem="disease" ids="C1709246" disease_type="Disease or Syndrome" abbrv="">nonneoplastic disease</z:e> for expression of CD43 and compared them with other sites and with CD20, CD138, and CD3 reactivity </plain></SENT>
<SENT sid="3" pm="."><plain>The majority of cases (85%) showed strong coexpression of CD43 by benign perifollicular B cells </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of CD43 coexpression in B-cell populations of the terminal ileum, including those of Peyer's patches, should not be used as a diagnostic parameter to differentiate extranodal marginal zone B-cell <z:hpo ids='HP_0002665'>lymphoma</z:hpo> of MALT type from reactive processes </plain></SENT>
</text></document>